Notes in 5 Rheum. Investi.

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/10/2024	Autoantibodies{{c1::Anti-Smith}} ‒ (highly specific to {{c2::SLE}} but not very sensitive)
Published	02/10/2024	Autoantibodies{{c1::Anti-double stranded DNA}} ‒ (highly specific to {{c2::SLE}})
Published	02/10/2024	Autoantibodies{{c1::Antiphospholipid antibodies}} ‒ (Found in 40% of SLE patients)
Published	02/10/2024	Autoantibodies{{c1::Anti-centromere antibodies}} ‒ (associated with {{c2::Limited cutaneous systemic sclerosis}})
Published	02/10/2024	Autoantibodies{{c1::Anti-Scl-70}} ‒ (most associated with {{c2::Diffuse cutaneous systemic sclerosis}})
Published	02/10/2024	Autoantibodies{{c1::Anti-Ro}} and {{c1::Anti-La}} (most associated with {{c2::Sjogren’s syndrome}})
Published	02/10/2024	Autoantibodies{{c2::Anti-Jo-1}} antibody ‒ (most associated with {{c1::Polymyositis}} and {{c1::Dermatomyositis}})
Published	02/10/2024	Autoantibodies{{c1::c-ANCA (anti-PR3)}} ‒ (associated with {{c2::Wegener’s}})
Published	02/10/2024	Autoantibodies{{c1::p-ANCA (anti-MPO)}} (Associated with {{c2::Microscopic polyangitis}} and {{c2::Churg-Strauss}})
Status	Last Update	Fields